GEN Exclusives

More »

GEN News Highlights

Back to Item »

GTx and Ipsen Fail to Show Benefit of Toremifene 20 mg in Prostate Cancer

NDA submission for 80 mg version prompted FDA to ask for a second Phase III trial.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?